ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,633,000 | +90.0% | 100,000 | 0.0% | 0.54% | +87.7% |
| Q1 2019 | $2,438,000 | +71.1% | 100,000 | 0.0% | 0.28% | +53.2% |
| Q4 2018 | $1,425,000 | -6.2% | 100,000 | 0.0% | 0.19% | +9.4% |
| Q3 2018 | $1,520,000 | -9.4% | 100,000 | 0.0% | 0.17% | -12.8% |
| Q2 2018 | $1,678,000 | +46.9% | 100,000 | +42.9% | 0.20% | +43.4% |
| Q1 2018 | $1,142,000 | +41.7% | 70,000 | +11.1% | 0.14% | +38.8% |
| Q4 2017 | $806,000 | +31.1% | 63,000 | +26.0% | 0.10% | +25.6% |
| Q3 2017 | $615,000 | +47.1% | 50,000 | 0.0% | 0.08% | +39.3% |
| Q2 2017 | $418,000 | -6.5% | 50,000 | 0.0% | 0.06% | -9.7% |
| Q1 2017 | $447,000 | +408.0% | 50,000 | +400.0% | 0.06% | +376.9% |
| Q4 2016 | $88,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |